Literature DB >> 21235693

Renin-angiotensin blockade in diabetic retinopathy.

A Ghattas, P-L Lip, G Y H Lip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21235693     DOI： 10.1111/j.1742-1241.2010.02592.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


× No keyword cloud information.
  9 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

2.  The TetO rat as a new translational model for type 2 diabetic retinopathy by inducible insulin receptor knockdown.

Authors:  Nadine Reichhart; Sergio Crespo-Garcia; Nadine Haase; Michaela Golic; Sergej Skosyrski; Anne Rübsam; Christina Herrspiegel; Norbert Kociok; Natalia Alenina; Michael Bader; Ralf Dechend; Olaf Strauss; Antonia M Joussen
Journal:  Diabetologia       Date:  2016-10-04       Impact factor: 10.122

3.  ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy.

Authors:  Amrisha Verma; Zhiying Shan; Bo Lei; Lihui Yuan; Xuan Liu; Takahiko Nakagawa; Maria B Grant; Alfred S Lewin; William W Hauswirth; Mohan K Raizada; Qiuhong Li
Journal:  Mol Ther       Date:  2011-07-26       Impact factor: 11.454

4.  Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats.

Authors:  Islam N Mohamed; Sahar A Soliman; Ahmed Alhusban; Suraporn Matragoon; Bindu A Pillai; Ahmed A Elmarkaby; Azza B El-Remessy
Journal:  Mol Vis       Date:  2012-06-02       Impact factor: 2.367

5.  Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina.

Authors:  G Foureaux; B S Nogueira; D C O Coutinho; M K Raizada; J C Nogueira; A J Ferreira
Journal:  Braz J Med Biol Res       Date:  2015-09-29       Impact factor: 2.590

6.  Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril.

Authors:  Preenie deS Senanayake; Vera L Bonilha; John W Peterson; Yoshiro Yamada; Sadashiva S Karnik; Firouz Daneshgari; K Bridget Brosnihan; Joe G Hollyfield
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Jul-Sep       Impact factor: 1.636

7.  Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.

Authors:  Wendy W Batenburg; Amrisha Verma; Yunyang Wang; Ping Zhu; Mieke van den Heuvel; Richard van Veghel; A H Jan Danser; Qiuhong Li
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

8.  Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.

Authors:  Tuhina Prasad; Lodi C W Roksnoer; Ping Zhu; Amrisha Verma; Yiming Li; Wendy W Batenburg; René de Vries; A H Jan Danser; Qiuhong Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-12-01       Impact factor: 4.799

9.  Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice.

Authors:  Amrisha Verma; Kang Xu; Tao Du; Ping Zhu; Zhibing Liang; Shengquan Liao; Juantao Zhang; Mohan K Raizada; Maria B Grant; Qiuhong Li
Journal:  Mol Ther Methods Clin Dev       Date:  2019-07-10       Impact factor: 6.698
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.